Cargando…
Effect of single-dose methotrexate injection to prevent neoplastic changes in high risk complete hydatidiform mole: A randomised control trial
BACKGROUND: Complete hydatidiform mole affects women in their reproductive age. About 15-20% develops persistent molar gestational trophoblastic neoplasia (GTN), which is linked with delayed (beyond 56 days) normalization of serum βHCG after surgical evacuation. OBJECTIVE: The objective of the artic...
Autores principales: | Biswas, Jhuma, Dasgupta, Shyamal, Datta, Mallika, Datta, Mousumi, Saha, Santa, Pradhan, Parthapratim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810940/ https://www.ncbi.nlm.nih.gov/pubmed/36618146 http://dx.doi.org/10.4103/jfmpc.jfmpc_208_22 |
Ejemplares similares
-
Hydatidiform Mole
Publicado: (1908) -
Hydatidiform Mole
por: Lodge, R.
Publicado: (1927) -
Prophylactic Chemotherapy with Methotrexate Leucovorin in High-Risk Hydatidiform Mole
por: Aminimoghaddam, Soheila, et al.
Publicado: (2020) -
Molecular and Immunohistochemical Characteristics of Complete Hydatidiform Moles
por: Kubelka-Sabit, KB, et al.
Publicado: (2017) -
Coexisting complete hydatidiform mole & live pregnancy
por: Kiran, M., et al.
Publicado: (2020)